POSTMARKETING SURVEILLANCE OF ADVERSE REACTIONS TO DRUGS

[1] POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 12 MONTH MORTALITY REPORT [J]. BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6379): : 1713 - 1716

[2] MONITORING ADVERSE REACTIONS TO DRUGS [J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6053) : 96 - 97

[3] GRIFFIN JP, MONITORING ADVERSE D

[4] ERYTHROMYCIN ESTOLATE AND JAUNDICE [J]. BRITISH MEDICAL JOURNAL, 1983, 286 (6382) : 1954 - 1955

[5] INMAN WHW, 1982, LANCET, V1, P1078

[6] INMAN WHW, 1980, MONITORING DRUG SAFE, P9

[7] INMAN WHW, 1982, PRESCRIPTION EVENT M

[8] INMAN WHW, 1977, DRUG MONITORING, P65

[9] LAWSON DH, 1977, BRIT MED J, V1, P691, DOI 10.1136/bmj.1.6062.691

[10] MANN JI, 1980, MONITORING DRUG SAFE, P401

[1] POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 12 MONTH MORTALITY REPORT [J]. BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6379): : 1713 - 1716

[2] MONITORING ADVERSE REACTIONS TO DRUGS [J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6053) : 96 - 97

[3] GRIFFIN JP, MONITORING ADVERSE D

[4] ERYTHROMYCIN ESTOLATE AND JAUNDICE [J]. BRITISH MEDICAL JOURNAL, 1983, 286 (6382) : 1954 - 1955

[5] INMAN WHW, 1982, LANCET, V1, P1078

[6] INMAN WHW, 1980, MONITORING DRUG SAFE, P9

[7] INMAN WHW, 1982, PRESCRIPTION EVENT M

[8] INMAN WHW, 1977, DRUG MONITORING, P65

[9] LAWSON DH, 1977, BRIT MED J, V1, P691, DOI 10.1136/bmj.1.6062.691

[10] MANN JI, 1980, MONITORING DRUG SAFE, P401